Biological Safety Testing Market: By Products (Instruments, Kits & Reagents), By Test Type (Endotoxin Tests, Sterility Test, Cell Line Authentication and Characterization Tests, Bioburden Tests, Residual Host Contaminant Detection Tests, Adventitious Agent Detection Tests, Toxicity Tests and Stability Tests), By Application (Vaccines & Therapeutics, Blood & Blood Products, Tissue & Tissue Products, Stem Cell Products, Gene Therapy and Cellular Therapy) & By Region - Forecast (2018- 2023)

Report Code : HCR 0430 Format Type: PDF+ Excel Database

Biological safety testing can be defined as knowledge, techniques and equipment to prevent personal, laboratory and environmental exposure to potentially infectious agents or biohazards. The major objective is to reduce the potential exposure of the laboratory worker, persons outside of the laboratory, and the environment to potentially infectious agents. Globally increasing instance of chronic diseases and growing biopharmaceutical industry is expected to remain key growth driver for the biological safety testing market during the period of study.

This report identifies the global biological safety testing market size in for the year 2015-2017, and forecast of the same for year 2022. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global biological safety testing market.

Biological Safety Testing Market

Geographically North America dominated the global biological safety testing market owing to developed healthcare infrastructure with standard guidelines & procedures, presence of global bio tech companies and pharmaceutical players and higher investment into R& activities in the region. North America was followed by Europe and Asia-Pacific as the second and third largest markets for biological safety testing. However Asia-Pacific is expected to remain the fastest growing market during the period of study driven by economic developments, developing healthcare infrastructure in the major economies such as India and China.

This report segments global biological safety testing market on the basis of product, test type, applications, end user and regional market as follows:
  • On the basis of product this report on global biological safety testing market is segmented as follows, covering all major products in the biological safety testing as follows: KITS & Reagents, and  Instruments
  • This report on global biological safety testing also covers in detail various applications of biological safety testing, some of the major applications covered in the report are Vaccines & Therapeutics, Blood & Blood Products, Tissue & Tissue Products, Stem Cell Products, Gene Therapy, and Cellular Therapy
  • This repot on global biological safety testing also covers in detail various test types of biological safety testing, some of the major test types covered in the report are Endotoxin Tests, Sterility Test, Cell Line Authentication and Characterization Tests, Bioburden Tests, Residual Host Contaminant Detection Tests, Adventitious Agent Detection Tests, Toxicity Tests, and Stability Tests
  • This report on biological safety testing has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets in each of the region

Sample Companies Profiled in this Report are:
  • Thermo Fisher Scientific Inc.
  • Charles River Laboratories International, Inc.
  • Merck KGaA
  • Avance Biosciences
  • WuXi PharmaTech (Cayman) Inc,
  • 30+.

PLEASE SELECT LICENCE

Request Sample Data